Analysis of metabolic disorders, including hypertension, dyslipidemia, and atherosclerosis, showed no significant correlation with the proportion of tumor-infiltrating CD28+PD1−/CD8+ T cells (Figure 3K). This evidence concerns the gene CD8A and atherosclerosis.